This is a StreetInsider.com Premium Only Page

(CKPT) – StreetInsider.com Reports

Mar 18, 2024 08:04 AM Checkpoint Therapeutics (CKPT) names Amit Sharma to board

Jan 29, 2024 08:01 AM Checkpoint Therapeutics (CKPT) Announces 7.76M Share Offering at $1.805/sh

Jan 5, 2024 05:09 PM Checkpoint Therapeutics (CKPT) Announces Resignation of Scott Boilen from Board

Dec 20, 2023 08:16 AM Checkpoint Therapeutics (CKPT) PT Lowered to $4 at B.Riley

Dec 18, 2023 08:58 AM Checkpoint Therapeutics (CKPT) PT Lowered to $8 at Lake Street Capital Markets

Dec 18, 2023 07:20 AM Checkpoint Therapeutics (CKPT) to Resume Trading at 7:30 a.m.

Dec 18, 2023 07:01 AM Checkpoint Therapeutics (CKPT) Announces FDA Issues CRL for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer

Dec 18, 2023 06:54 AM Checkpoint Therapeutics (CKPT) Halted, News Pending

Nov 15, 2023 08:42 AM Checkpoint Therapeutics (CKPT) PT Lowered to $8 at Lake Street Capital Markets

Nov 14, 2023 04:23 AM Checkpoint Therapeutics (CKPT ) Tops Q3 EPS by 46c

Oct 18, 2023 08:32 AM Checkpoint Therapeutics (CKPT) Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer

Aug 15, 2023 12:13 PM Checkpoint Therapeutics (CKPT) PT Lowered to $14 at Lake Street Capital Markets

Aug 15, 2023 06:32 AM Checkpoint Therapeutics (CKPT) PT Lowered to $14 at Cantor Fitzgerald

Jul 31, 2023 08:01 AM Checkpoint Therapeutics (CKPT) Announces 3.24M Share Offering at $3.09/sh

Jul 27, 2023 07:01 AM Checkpoint Therapeutics (CKPT) Reports Cosibelimab Longer-Term Results Demonstrating Substantial Increases in Complete Response Rates

May 23, 2023 08:31 AM Checkpoint Therapeutics (CKPT) Prices 3.27M Share Offering at $3.07/sh

Apr 28, 2023 06:36 AM Checkpoint Therapeutics (CKPT) PT Lowered to $34 at H.C. Wainwright

Apr 4, 2023 09:07 AM Checkpoint Therapeutics (CKPT) PT Lowered to $22 at Lake Street Capital Markets

Mar 31, 2023 08:05 AM Checkpoint Therapeutics (CKPT) Announces $6.1 Million Registered Direct Offering of Common Stock, Warrants

Mar 27, 2023 05:59 AM Checkpoint Therapeutics (CKPT) Files $150M Mixed Shelf

Mar 2, 2023 07:05 AM Checkpoint Therapeutics (CKPT) Announces FDA Filing Acceptance of BLA for Cosibelimab

Feb 21, 2023 08:02 AM Checkpoint Therapeutics (CKPT) Announces 1.43M Share Direct Offering at $5.25/sh

Feb 14, 2023 07:06 AM Checkpoint Therapeutics (CKPT) PT Raised to $136 at JPMorgan

Jan 5, 2023 08:55 AM Checkpoint Therapeutics (CKPT) PT Lowered to $41 at Lake Street Capital Markets

Jan 4, 2023 10:47 AM H.C. Wainwright Reiterates Buy Rating on Checkpoint Therapeutics (CKPT) as BLA Filed

Dec 27, 2022 07:49 AM Checkpoint Therapeutics (CKPT) PT Raised to $76 at H.C. Wainwright

Dec 19, 2022 08:00 AM Checkpoint Therapeutics (CKPT) PT Raised to $15 at B.Riley

Dec 15, 2022 08:01 AM Checkpoint Therapeutics (CKPT) Prices 1.73M Share Direct Offering at $4.33/sh

Dec 5, 2022 04:32 PM Checkpoint Therapeutics (CKPT) Announces 1-for-10 Reverse Stock Split

Jul 14, 2022 07:44 AM B.Riley Resumes Checkpoint Therapeutics (CKPT) at Buy

Jun 16, 2022 07:30 AM Checkpoint Therapeutics (CKPT) Reports Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Locally Advanced Cutaneous Squamous Cell Carcinoma

Jun 6, 2022 04:31 PM Checkpoint Therapeutics (CKPT) Announces Presentation of Pivotal Trial Results of Cosibelimab

May 13, 2022 08:31 AM Checkpoint Therapeutics (CKPT) Granted Pediatric Investigational Plan Waivers for Cosibelimab in Europe and UK

May 13, 2022 06:19 AM Cantor Fitzgerald Reiterates Overweight Rating on Checkpoint Therapeutics (CKPT) on Q1 Report

Apr 27, 2022 05:55 AM Veru (VERU) and Opiant (OPNT) Top Cantor Fitzgerald's List of Largest Short Interest Increases

Jan 26, 2022 08:24 AM Checkpoint Therapeutics (CKPT) PT Raised to $26 at Ladenburg Thalmann

Jan 25, 2022 09:24 AM Pre-Open Stock Movers 01/25: (CKPT) (SDC) (AMRN) Higher; (AJRD) (GE) (NVDA) Lower (more...)

Jan 25, 2022 08:23 AM Checkpoint's (CKPT) cosibelimab Data Checks Right Boxes and Provides Further Validation of Potential - Cantor Fitzgerald

Jan 25, 2022 08:22 AM Checkpoint Therapeutics (CKPT) PT Raised to $26 at H.C. Wainwright Following Positive Data

Jan 25, 2022 08:20 AM Checkpoint Therapeutics (CKPT) PT Raised to $20 at Cantor Fitzgerald Following Positive Data

Jan 25, 2022 07:42 AM Checkpoint Therapeutics (CKPT) to Resume Trading at 8 a.m.

Jan 25, 2022 07:31 AM Checkpoint Therapeutics (CKPT) Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma Met its Primary Endpoint

Jan 25, 2022 07:25 AM Checkpoint Therapeutics (CKPT) Halted, News Pending

Jun 9, 2021 07:13 AM B.Riley Starts Checkpoint Therapeutics (CKPT) at Buy, PT $18, 'taking a little bite of a big pie'

Jun 9, 2021 07:11 AM Checkpoint Therapeutics (CKPT) Climbs 80%

Apr 21, 2021 09:02 AM Companies with NDRs 4/21

Apr 19, 2021 06:48 AM Companies with NDRs 4/19

Jan 20, 2021 09:20 AM Pre-Open Stock Movers 01/20: (APM) (EVLO) (NFLX) Higher; (GEVO) (HSTO) (BLRX) Lower (more...)

Jan 19, 2021 05:44 PM After-Hours Stock Movers 01/19: (NFLX) (CKPT) (PCAR) Higher; (HSTO) (BLRX) (ACRX) Lower (more...)

Jan 19, 2021 04:04 PM Cantor Fitzgerald Starts Checkpoint Therapeutics (CKPT) at Overweight